Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-891X
ISSN (Online): 2212-4071

Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance

Author(s):Ashima K. Bhardwaj, Kittappa Vinothkumar and Neha Rajpara

Volume 8, Issue 1, 2013

Page: [68 - 83]Pages: 16

DOI:10.2174/1574891X11308010012

Price: $65

Abstract

Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. Itinvolves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array offunctions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since QS is responsible for virulencein the clinically relevant bacteria, inhibition of QS appears to be a promising strategy to control these pathogenicbacteria. With indiscriminate use of antibiotics, there has been an alarming increase in the number of antibiotic resistantpathogens. Antibiotics are no longer the magic bullets they were once thought to be and therefore there is a need fordevelopment of new antibiotics and/or other novel strategies to combat the infections caused by multidrug resistant organisms.Quorum sensing inhibition or quorum quenching has been pursued as one of such novel strategies. While antibioticskill or slow down the growth of bacteria, quorum sensing inhibitors (QSIs) or quorum quenchers (QQs) attenuate bacterialvirulence. A large body of work on QS has been carried out in deadly pathogens like Pseudomonas aeruginosa,Staphylococcus aureus, Vibrio fischeri, V. harveyi, Escherichia coli and V. cholerae etc to unravel the mechanisms of QSas well as identify and study QSIs. This review describes various aspects of QS, QSI, different model systems to studythese phenomena and recent patents on various QSIs. It suggests QSIs as attractive alternatives for controlling human,animal and plant pathogens and their utility in agriculture and other industries.

Keywords:Biofilms, multidrug resistance, patents, Pseudomonas aeruginosa, quorum sensing, quorum sensing inhibitors,Staphylococcus aureus, Vibrio cholerae, Autoinducer type 1, QS systems


Rights & PermissionsPrintCite

Recent Patents on Anti-Infective Drug Discovery

Title:Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance

Volume: 8Issue: 1

Author(s):Ashima K. Bhardwaj, Kittappa Vinothkumar and Neha Rajpara

Affiliation:

        Keywords:Biofilms, multidrug resistance, patents, Pseudomonas aeruginosa, quorum sensing, quorum sensing inhibitors,Staphylococcus aureus, Vibrio cholerae, Autoinducer type 1, QS systems

        Abstract: Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. Itinvolves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array offunctions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since QS is responsible for virulencein the clinically relevant bacteria, inhibition of QS appears to be a promising strategy to control these pathogenicbacteria. With indiscriminate use of antibiotics, there has been an alarming increase in the number of antibiotic resistantpathogens. Antibiotics are no longer the magic bullets they were once thought to be and therefore there is a need fordevelopment of new antibiotics and/or other novel strategies to combat the infections caused by multidrug resistant organisms.Quorum sensing inhibition or quorum quenching has been pursued as one of such novel strategies. While antibioticskill or slow down the growth of bacteria, quorum sensing inhibitors (QSIs) or quorum quenchers (QQs) attenuate bacterialvirulence. A large body of work on QS has been carried out in deadly pathogens like Pseudomonas aeruginosa,Staphylococcus aureus, Vibrio fischeri, V. harveyi, Escherichia coli and V. cholerae etc to unravel the mechanisms of QSas well as identify and study QSIs. This review describes various aspects of QS, QSI, different model systems to studythese phenomena and recent patents on various QSIs. It suggests QSIs as attractive alternatives for controlling human,animal and plant pathogens and their utility in agriculture and other industries.

        Export Options

        About this article

        Cite this article as:

        K. Bhardwaj Ashima, Vinothkumar Kittappa and Rajpara Neha, Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance, Recent Patents on Anti-Infective Drug Discovery 2013; 8 (1) .https://dx.doi.org/10.2174/1574891X11308010012

        DOI
        https://dx.doi.org/10.2174/1574891X11308010012
        Print ISSN
        1574-891X
        Publisher Name
        Bentham Science Publisher
        Online ISSN
        2212-4071
        Related Journals

        Anti-Cancer Agents in Medicinal Chemistry

        Current Bioactive Compounds

        Current Drug Safety

        Current Drug Targets

        Current Medicinal Chemistry

        Current Pharmaceutical Biotechnology

        Central Nervous System Agents in Medicinal Chemistry

        Infectious Disorders - Drug Targets

        Letters in Drug Design & Discovery

        Current HIV Research

        Related Books

        Vector Borne Diseases: Current Trends and Public Health Perspectives

        Concise Handbook of Epidemiology (Second Edition)

        Human Papillomavirus Vaccination and Screening in the Elimination of HPV-Associated Cancers: Evidence-Based Randomized Trials

        COVID-19: Causes, Transmission, Diagnosis, and Treatment

        Computer-Aided Drug Discovery Methods: A Brief Introduction

        Infectious Diseases

        Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product

        Marine Biopharmaceuticals: Scope and Prospects

        COVID 19 - Monitoring with IoT Devices

        Frontiers in Clinical Drug Research-Anti Infectives

        Article Metrics
        360
        Related Articles
        © 2025 Bentham Science Publishers |Privacy Policy

        [8]ページ先頭

        ©2009-2025 Movatter.jp